Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China · Delayed Price · Currency is CNY 10.55
-0.43 (-3.92%)
May 21, 2026, 3:04 PM CST
SHE:002693 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 32.53 | 19.04 | -78.3 | -50.74 | 9.01 | -20.33 |
Depreciation & Amortization | 52.62 | 52.62 | 53.48 | 52.67 | 57.54 | 54.33 |
Other Amortization | 2.48 | 2.48 | 1.98 | 1.37 | 0.98 | 1.16 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | 0.02 | -0.47 | -29.91 | -13.79 |
Asset Writedown & Restructuring Costs | 2.88 | 2.88 | 19.01 | 0.12 | 2.12 | 0.05 |
Loss (Gain) From Sale of Investments | -0.57 | -0.57 | 9.4 | 37.1 | -4.63 | -4.12 |
Provision & Write-off of Bad Debts | 0.09 | 0.09 | 0.18 | 1.15 | -0.09 | -0.05 |
Other Operating Activities | 13.8 | 2.26 | -18.42 | -8.29 | -5.27 | -8.61 |
Change in Accounts Receivable | -51.02 | -51.02 | -3.48 | 4.99 | -13.83 | 5.39 |
Change in Inventory | 11.94 | 11.94 | -19.76 | -12.45 | -9.89 | -4.77 |
Change in Accounts Payable | 22.01 | 22.01 | -5.02 | -9.66 | 19.57 | 13.83 |
Change in Other Net Operating Assets | - | - | - | -3.17 | - | - |
Operating Cash Flow | 85.98 | 60.95 | -40.83 | 11.64 | 25.22 | 23.55 |
Operating Cash Flow Growth | - | - | - | -53.84% | 7.07% | - |
Capital Expenditures | -46.72 | -43.27 | -24.91 | -49.2 | -32.98 | -31.64 |
Sale of Property, Plant & Equipment | 1.06 | 1.06 | 0.78 | 9.83 | 26.98 | 21.67 |
Investment in Securities | 20.96 | -0.28 | 28.48 | 61.03 | -83.76 | 38.85 |
Other Investing Activities | 0.52 | 0.56 | 0.69 | 2.75 | 4.69 | 4.12 |
Investing Cash Flow | -24.17 | -41.93 | 5.04 | 24.42 | -85.07 | 32.99 |
Short-Term Debt Issued | - | 8.49 | 22.45 | 22.94 | 7.61 | - |
Long-Term Debt Issued | - | 29 | 80 | - | 50 | - |
Total Debt Issued | 47.49 | 37.49 | 102.45 | 22.94 | 57.61 | - |
Short-Term Debt Repaid | - | -7.35 | -1.83 | -1.15 | - | - |
Long-Term Debt Repaid | - | -28 | -12.5 | -60 | -12 | -55.34 |
Total Debt Repaid | -35.35 | -35.35 | -14.33 | -61.15 | -12 | -55.34 |
Net Debt Issued (Repaid) | 12.15 | 2.15 | 88.12 | -38.2 | 45.61 | -55.34 |
Issuance of Common Stock | - | - | 0.42 | 7.42 | 10.45 | 13.37 |
Common Dividends Paid | -7.22 | -7.27 | -7.19 | -8.69 | -11.13 | -9.1 |
Other Financing Activities | -3.71 | - | -4.01 | - | - | 10.45 |
Financing Cash Flow | 1.22 | -5.12 | 77.34 | -39.47 | 44.93 | -40.62 |
Foreign Exchange Rate Adjustments | -0.73 | 0.04 | 0.17 | -0 | 0.1 | -0.11 |
Net Cash Flow | 62.29 | 13.94 | 41.72 | -3.41 | -14.82 | 15.82 |
Free Cash Flow | 39.26 | 17.68 | -65.73 | -37.56 | -7.77 | -8.09 |
Free Cash Flow Margin | 13.61% | 6.39% | -37.73% | -15.92% | -2.83% | -2.52% |
Free Cash Flow Per Share | 0.10 | 0.05 | -0.16 | -0.09 | -0.02 | -0.02 |
Cash Income Tax Paid | 15.66 | 14.15 | 14.84 | 31.92 | 18.04 | 31.61 |
Levered Free Cash Flow | 24.01 | 11.71 | -31.22 | -31.8 | -23.48 | 27.13 |
Unlevered Free Cash Flow | 29.96 | 17.74 | -25.45 | -25.81 | -16.49 | 32.78 |
Change in Working Capital | -17.84 | -17.84 | -28.16 | -21.27 | -4.53 | 14.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.